- Active not recruitingPHASE3
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
This study looks at a new medicine called Povorcitinib for moderate to severe hidradenitis suppurativa (HS). It's for people who have already finished an earlier study. We want to see how safe and effective it is over a longer time.
For: Hidradenitis Suppurativa (HS)United States · Australia · Austria - Active not recruitingPHASE3
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
This study is looking into a new medication called povorcitinib for people with prurigo nodularis, a skin condition causing very itchy bumps. It aims to see how well it reduces itching and skin problems, and if it's safe to use.
For: Prurigo NodularisUnited States · Australia · Belgium - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
This study is testing a new medicine, povorcitinib, for people with moderate to severe hidradenitis suppurativa (HS). It compares the new medicine to a dummy pill to see if it helps reduce HS symptoms and pain, and improve quality of life.
For: Hidradenitis SuppurativaBelgium · Germany · Austria - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
This study is testing a new medicine called Povorcitinib for people with moderate to severe hidradenitis suppurativa (HS). It compares the medicine to a dummy pill to see if it helps reduce HS symptoms and pain, and improves quality of life.
For: Hidradenitis SuppurativaPoland · Germany · Bulgaria - Ongoing, recruitingTherapeutic exploratory (Phase II)
Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy, and Safety Study of Povorcitinib in Participants With Chronic Spontaneous Urticaria
This study is testing a new medicine, Povorcitinib, for people with chronic spontaneous urticaria (CSU), also known as chronic hives. It aims to see if the drug helps reduce itching and hives and if it's safe, compared to a dummy pill.
For: Chronic Spontaneous UrticariaGermany · Poland - Active not recruitingPHASE3
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
This study is testing a new medicine called povorcitinib for people with a type of vitiligo called nonsegmental vitiligo. Researchers want to see if it's safe and helps improve the skin patches. It's a Phase 3 trial, meaning it's a later stage of research.
For: NonSegmental VitiligoUnited States · Bulgaria · Canada - RecruitingPHASE3
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
This study is for people who have already taken part in certain Incyte povorcitinib trials for Hidradenitis Suppurativa (HS) and found the treatment helpful. It allows them to continue receiving the study drug if their doctor agrees it's safe and beneficial.
For: Hidradenitis Suppurativa (HS)United States · Argentina · Australia